Wolfgang Sippl mainly focuses on Biochemistry, Histone, Docking, NAD+ kinase and Histone deacetylase. His is involved in several facets of Biochemistry study, as is seen by his studies on Sirtuin, Enzyme, SIRT2, Methyltransferase and Enzyme inhibitor. The study incorporates disciplines such as Cell cycle, Epigenetics and Lysine in addition to Histone.
Docking is a subfield of Stereochemistry that he explores. He has included themes like Homology modeling and G protein-coupled receptor in his Stereochemistry study. As a part of the same scientific family, Wolfgang Sippl mostly works in the field of Nicotinamide adenine dinucleotide, focusing on Histone deacetylase 5 and, on occasion, HDAC8 and Histone Demethylases.
Wolfgang Sippl spends much of his time researching Biochemistry, Docking, Stereochemistry, Drug discovery and Histone. Enzyme, NAD+ kinase, Sirtuin, Kinase and SIRT2 are the subjects of his Biochemistry studies. Wolfgang Sippl combines subjects such as Quantitative structure–activity relationship, In vitro, Structure–activity relationship and HDAC8 with his study of Docking.
His Stereochemistry research incorporates themes from Receptor and Binding site. His studies deal with areas such as Medicinal plants and Traditional medicine as well as Drug discovery. Computational biology is closely connected to Epigenetics in his research, which is encompassed under the umbrella topic of Histone.
His main research concerns Docking, Computational biology, Drug discovery, Biochemistry and Stereochemistry. His Docking study combines topics in areas such as Apocynaceae, Voacanga africana, Alkaloid, Enzyme and HDAC8. His studies deal with areas such as Binding free energy, Molecular model, Pharmacophore, In silico and Epigenetics as well as Computational biology.
The concepts of his Drug discovery study are interwoven with issues in Histone deacetylase, Natural product and Medicinal plants. His work on Lysine, Butyrylcholinesterase and Small molecule as part of his general Biochemistry study is frequently connected to Monoamine oxidase B and Urolithin, thereby bridging the divide between different branches of science. Wolfgang Sippl interconnects Tertiary amine, Biological activity and Bacteria in the investigation of issues within Stereochemistry.
His primary scientific interests are in Drug discovery, Computational biology, Biochemistry, Cancer research and Docking. His Drug discovery research is multidisciplinary, incorporating perspectives in Natural product and Class iii. His Computational biology research incorporates themes from Sirtuin, Protein degradation, Proteolysis and Proteasome.
Wolfgang Sippl conducted interdisciplinary study in his works that combined Biochemistry and Side chain. His Cancer research research includes themes of Virtual screening, In vitro, Growth inhibition, Histone and Regulation of gene expression. His Docking research is multidisciplinary, relying on both Acetylation, Phenothiazine, HDAC1, HDAC4 and HDAC6.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
Patrice Dubreuil;Sébastien Letard;Marco Ciufolini;Laurent Gros.
PLOS ONE (2009)
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Frédéric Colland;Etienne Formstecher;Xavier Jacq;Céline Reverdy.
Molecular Cancer Therapeutics (2009)
Discovery of Specific Inhibitors of Human USP7/HAUSP Deubiquitinating Enzyme
Céline Reverdy;Susan Conrath;Roman Lopez;Cécile Planquette.
Chemistry & Biology (2012)
Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.
Tobias Rumpf;Matthias Schiedel;Berin Karaman;Claudia Roessler.
Nature Communications (2015)
Structure–Activity Studies on Suramin Analogues as Inhibitors of NAD+‐Dependent Histone Deacetylases (Sirtuins)
Johannes Trapp;Rene Meier;Darunee Hongwiset;Matthias U. Kassack.
HDAC8: a multifaceted target for therapeutic interventions
Alokta Chakrabarti;Ina Oehme;Olaf Witt;Guilherme Oliveira.
Trends in Pharmacological Sciences (2015)
Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
Matthias Schiedel;Daniel Herp;Sören Hammelmann;Sören Swyter.
Journal of Medicinal Chemistry (2018)
The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
Astrid Spannhoff;Astrid Spannhoff;Alexander‐Thomas Hauser;Ralf Heinke;Wolfgang Sippl.
Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition
Johannes Trapp;Anne Jochum;Rene Meier;Laura Saunders.
Journal of Medicinal Chemistry (2006)
Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode.
Robert C. Neugebauer;Urszula Uchiechowska;Rene Meier;Henning Hruby.
Journal of Medicinal Chemistry (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: